{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20200915",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "64580",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022332Orig1s011ltr.pdf",
              "date": "20200921",
              "type": "Letter"
            },
            {
              "id": "64629",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022332Orig1s011lbl.pdf",
              "date": "20201006",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20140429",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "17252",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022332s006lbl.pdf",
              "date": "20140502",
              "type": "Label"
            },
            {
              "id": "29608",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022332Orig1s006ltr.pdf",
              "date": "20140430",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20090522",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 6",
          "submission_class_code_description": "Type 6 - New Indication (no longer used)",
          "application_docs": [
            {
              "id": "7247",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022332s000ltr.pdf",
              "date": "20090529",
              "type": "Letter"
            },
            {
              "id": "17251",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022332lbl.pdf",
              "date": "20090525",
              "type": "Label"
            },
            {
              "id": "21996",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022332_adcirca_toc.html",
              "date": "20090803",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20170505",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "48305",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022332Orig1s009ltr.pdf",
              "date": "20170509",
              "type": "Letter"
            },
            {
              "id": "48333",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022332s009lbl.pdf",
              "date": "20170509",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20150402",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "7249",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/022332Orig1s007ltr.pdf",
              "date": "20150403",
              "type": "Letter"
            },
            {
              "id": "17253",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022332s007lbl.pdf",
              "date": "20150407",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20131120",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "38589",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022332s005lbl.pdf",
              "date": "20131122",
              "type": "Label"
            },
            {
              "id": "29607",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022332Orig1s005ltr.pdf",
              "date": "20131125",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20110208",
          "review_priority": "UNKNOWN",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "38588",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022332s003lbl.pdf",
              "date": "20110209",
              "type": "Label"
            },
            {
              "id": "7248",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022332s003ltr.pdf",
              "date": "20110214",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA022332",
      "sponsor_name": "ELI LILLY CO",
      "openfda": {
        "application_number": [
          "NDA022332"
        ],
        "brand_name": [
          "ADCIRCA"
        ],
        "generic_name": [
          "TADALAFIL"
        ],
        "manufacturer_name": [
          "United Therapeutics Corporation"
        ],
        "product_ndc": [
          "66302-467"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "TADALAFIL"
        ],
        "rxcui": [
          "849866",
          "2123194"
        ],
        "spl_id": [
          "76c30323-0981-499c-b552-1a43f01c89c8"
        ],
        "spl_set_id": [
          "ff61b237-be8e-461b-8114-78c52a8ad0ae"
        ],
        "package_ndc": [
          "66302-467-60"
        ],
        "nui": [
          "N0000175599",
          "N0000020026"
        ],
        "pharm_class_epc": [
          "Phosphodiesterase 5 Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Phosphodiesterase 5 Inhibitors [MoA]"
        ],
        "unii": [
          "742SXX0ICT"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "ADCIRCA",
          "active_ingredients": [
            {
              "name": "TADALAFIL",
              "strength": "20MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription",
          "te_code": "AB2"
        }
      ]
    }
  ]
}